Developments EC grants orphan medicinal product designation of Theriva’s VCN-01 for retinoblastoma Theriva Biologics (NYSE American:TOVX) has announced that the European Commission (EC) has adopted the European Medicines Agency’s (EMA) recommendation to grant orphan medicinal product designation to its lead... October 16, 2024